“My dad died a brutal death, and this COVID situation is real, and I would hate for someone to go through what my dad went through.”
Those are the words of Mike Madry, whose father Daniel passed away last month from COVID less than two weeks after being admitted to a Florida hospital.
Read MoreMadry added: “He was never told once the vaccine wouldn't work for him.”
Daniel’s death has shattered his family, and Madry wants to make sure no other family feels what he sees as a senseless pain.
Madry says his father was always masked and social distanced without issue prior to getting the vaccine and would have continued to do as much were he not of the belief that he was safe from the virus.
He had not been receiving treatment at the time, with his doctor having adopted a wait-and-see approach with his cancer, according to his son.
Then he caught COVID, and in less than two weeks was gone.
“I just hope his story will allow someone who might have CLL (chronic lymphocytic leukemia) or another disease that leaves them immunocompromised to realize the vaccine might not protect you from COVID," said Madry.
Can Leukemia Patients Get the Booster Shot for COVID-19?
A panel comprised of the nation’s leading medical experts on immunizations recommended on Aug. 13 that all individuals who are receiving treatment for hematologic cancers such as leukemia seek out a third booster shot of the COVID-19 vaccine.
That decision was made a little over 12 hours after the Food and Drug Administration granted emergency use authorizations for a third dose of the Moderna and Pfizer COVID-19 vaccines in immunosuppressed persons.
Once the additional dosage was approved, it fell to the members of the Centers for Disease Control Advisory Committee on Immunization Practices (ACIP) to determine for whom it was approved.
After a four-hour meeting, the group recommended that moderately to severely immunocompromised people should seek out a booster shot.
The group then gave six examples of patients who would be classified as moderately to severely immunocompromised, starting with those who have “been receiving active cancer treatment for tumors or cancers of the blood.”
COVID vaccines have proven to be less effective in cancer patients receiving chemotherapy, immunotherapy, biological therapy, or any combination of the three; and at times ineffective in those being treated for hematologic cancers.
This came just days after a pair of studies published in The Journal of the American Medical Association also determined that cancer patients have fewer antibodies than individuals who are not immunosuppressed when they first receive the vaccine, and after their second dose.
Dr. Thomas Martin explains what blood cancer patients should do after the COVID-19 vaccine
Can Leukemia Survivors Who Are Not in Active Treatment Get a Booster?
In its recommendations, the Centers for Disease Control Advisory Committee on Immunization Practices was clear that it considers patients “receiving active cancer treatments” as immunocompromised.
Those are the only cancer patients that the ACIP cites in its recommendations, but the group says that any person who is immunocompromised can and should receive a booster shot if their doctor approves of the measure.
5 COVID-19 Vaccine Questions Answered by Expert Physician
Learn more about SurvivorNet's rigorous medical review process.